This stock has been showing accelerated earnings and very strong EPS growth. The price is also showing good strength, it has been trending up since mid-December. Price is above 50 and 20 ema , both the ema's are slanting upwards. Institutions have also increased their holdings. This stock has a very healthy mix of sales growth, EPS growth, profit growth and ROE of 20%. All of these combinations make it a strong case to purchase this stock.


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.